Eastern Cooperative Oncology Group study 1879: Mitotane and adriamycin in patients with advanced adrenocortical carcinoma

Surgery

Volumn 110, Issue 6, 1991, Pages 1006-1013

  Decker, Ruth A ^a,b,c,d   Elson, Paul ^a,b,c,d,e   Hogan, Tom F ^a,b,c,d,e   Citrin, Dennis L ^a,b,c,d,e   Westring, David W ^a,b,c,d,e   Banerjee, Tarit K ^a,b,c,d,e   Gilchrist, Kennedy W ^a,b,c,d,e   Horton, John ^a,b,c,d,e  

^a MARSHFIELD CLINIC   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE ACETATE; DOXORUBICIN; FLUDROCORTISONE; MITOTANE;

ADRENAL CORTEX CARCINOMA; ADULT; ADVANCED CANCER; BLOOD TOXICITY; CARDIOTOXICITY; CONFERENCE PAPER; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PRIORITY JOURNAL;

ADRENAL CORTEX NEOPLASMS; ADULT; AGED; CARCINOMA; DOXORUBICIN; DRUG EVALUATION; FEMALE; HUMAN; MALE; MIDDLE AGE; MITOTANE; PROSPECTIVE STUDIES; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0026343069     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. O,p′-DDD (mitotane) therapy of adrenal cortical carcinoma: observations on drug dosage, toxicity, and steroid replacement
2. A clinical and pathological study of adrenocortical carcinoma: therapeutic implications
3. The clinical and pathologic features of “nonhormonal” adrenocortical tumors
4. Chemotherapy of adrenocortical carcinoma with o,p′-DDD
5. Adrenal cortical carcinoma: results of treatment with o,p′-DDD in 138 patients
6. Treatment of adrenocortical carcinoma with o,p′-DDD
7. Mitotane use in inoperable adrenal cortical carcinoma
8. Adrenal cortical carcinoma
9. Clinical and laboratory findings and results of therapy in fifty-eight patients with adrenocortical tumors admitted to a single medical center (1951 to 1978)
10. Treatment of adrenal carcinomas
11. The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic simplifications of serum level monitoring
12. Adrenal cortical carcinoma
13. Cisplatin (CDDP) and mitotane in metastatic adrenal carcinoma: a Southwest Oncology Group study [Abstract]
14. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy
15. 5-Fluorouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma
16. Treatment of genitourinary tumors with cis-dichlorodiamineplatinum (II): experience in 250 patients